Purpose: This phase II, open-label, multicenter study assessed the efficacy and safety of the potential radiation enhancer RSR13 plus cranial radiation therapy (RT) in patients with brain metastases.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback